Showing results (1-10 of 472) with videos related to
Sort By:
Pageof 48
Expert Review of Molecular Diagnostics|September 26, 2007
Plasma-based testing as a new paradigm for clinical testing in hematologic diseasesFrancis J Giles, Maher AlbitarCurrent Molecular Medicine|November 25, 2005
Mammalian target of rapamycin as a therapeutic target in leukemiaFrancis J Giles, Maher AlbitarCurrent Molecular Medicine|November 25, 2005
Monoclonal antibodies in the treatment of leukemiaSusan O'Brien, Maher Albitar, Francis J GilesLeukemia Research|March 7, 2003
Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alpha levels during treatmentApostolia Maria Tsimberidou, Tracey Waddelow, Hagop M Kantarjian, et al.Leukemia Research|October 12, 2004
Alemtuzumab: validation of a sensitive and simple enzyme-linked immunosorbent assayIman Jilani, Michael Keating, Francis J Giles, et al.Blood|March 6, 2002
Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemiaSrdan Verstovsek, Hagop Kantarjian, Taghi Manshouri, et al.Cancer|February 25, 2003
Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemiaSrdan Verstovsek, Hagop Kantarjian, Taghi Manshouri, et al.Leukemia Research|September 29, 2007
Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategyIman Jilani, Hagop Kantarjian, Mercedes Gorre, et al.Leukemia Research|May 26, 2004
Telomerase activity is not a prognostic factor in chronic lymphocytic leukemiaSrdan Verstovsek, Francis J Giles, Susan O'Brien, et al.Cancer|May 13, 2004
The clinical significance of large cells in bone marrow in patients with chronic lymphocytic leukemiaYupo Ma, Adnan Mansour, B Nebiyou Bekele, et al.Pageof 48